Market Research Future has developed a concise study on the ORAL MUCOSITIS MARKET to depict valuable insights related to significant market trends driving the industry.
Oral Mucositis Market Size, Growth
and Trends By Cause (Oral Mucositis Caused by Chemotherapy, Oral
Mucositis Caused by Radiotherapy, Oral Mucositis Caused by Hematopoietic
Stem Cell Transplantation, and Others ), End-User (Hospitals, Dental
Clinics, Oncology Hospitals, and Research Institutes), and Region
(Americas, Europe, Asia-Pacific, and Middle East & Africa)—Global
Forecast till 2025
Also Read:https://www.medgadget.com/
Rising Incidence of Anal Cancer to Drive Oral Mucositis Market
Market Research Future (MRFR) announces a new release examining the global oral mucositis market. The report examines the segmentation and competitive dynamics of the global Oral Mucositis Market Trends and presents readers with forecasts for the 2017-23 forecast period. According to the report, the global oral mucositis market is expected to grow at a CAGR of 7% over the forecast period.
Oral mucositis is a
disease comprising of lesions on the mucosal membranes of the mouth.
The highly painful condition often develops as a side effect of cancer
treatment and increases in severity in accordance with the severity of
the chemo treatment. While the disease itself is not threatening, its
effects can be deadly for the patient, as the excruciating pain can
render a person unable to swallow and eat solid food, making it
difficult to fulfill their nutritional requirements. Thus, oral
mucositis can indirectly affect a person’s nutritional profile and lead
to disastrous consequences. The open sores also present an infection
risk and can thus lead to other diseases that can sneak in through the
open wounds. Thus, while oral mucositis presents as a fairly minor
condition, its consequences can be debilitating and devastating for
patients, particularly those already suffering from cancer.
The
rising incidence of cancer is the prime driver for the global oral
mucositis market. The widespread use of chemotherapy, due to the absence
of feasible alternatives, is also a contributing factor to the growth
of the global oral mucositis market. Cancer has been rising in
prevalence across the world over the last few decades and especially in
developing regions such as Asia Pacific (APAC), cancer is spreading
rapidly. This has led to a rise in the prevalence of other diseases
associated with cancer, such as oral mucositis. Since oral mucositis
rarely arises on its own, the oral mucositis market is largely dependent
on the spread of cancer.
Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/1531
Segmental Analysis:
The global oral mucositis market is segmented on the basis of cause and end use.
By
cause, the oral mucositis market is segmented into chemotherapy,
radiotherapy, and hematopoietic stem cell transplantation. Chemotherapy
is the leading cause of oral mucositis and is likely to remain the same
over the forecast period.
By end user, the hospitals and oncology
hospitals segments dominate the global oral mucositis market due to its
close association with cancer. Other end users include dental clinics
and research institutes.
Browse Complete Toc : https://www.marketresearchfuture.com/reports/oral-mucositis-market-1531
Regional Analysis:The
global oral mucositis market is divided by geography into the Americas,
Europe, APAC, and the Middle East and Africa. The Americas dominate the
global oral mucositis market due to the widespread prevalence of cancer
and widespread use of chemo- and radiotherapy to treat it. On the other
hand, the oral mucositis market in APAC is rising at a steady rate and
is likely to emerge as a key segment in the coming years. In the
Americas, particularly North America, branded drugs are the major
medicine for oral mucositis due to the presence of a highly developed
medical industry. The incidence rate of anal cancer is the highest in
North America among these regional segments, making it the leader in the
global oral mucositis market.
Europe, APAC, and MEA markets for oral
mucositis are all expected to grow considerably over the forecast
period, though the incidence of anal cancer in MEA is the lowest and is
likely to remain low over the forecast period.
Competitive Analysis:Key
players in the global oral mucositis market include Shoreline
Pharmaceuticals Inc., Izun Pharmaceutical Ltd., AMAG Pharmaceuticals
Inc., Celleutix Corporation, Himalaya, Oragenics, Kinnear
Pharmaceuticals, and Soligenix Inc.
Related Report: eClinical Solutions Market Research Report – Global Forecast till 2023 – https://www.marketresearchfuture.com/infographics/eclinical-solution-market
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.
